Bank Of America Corp Orchard Therapeutics PLC Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$0.36 - $0.49 $19,152 - $26,068	-53,202 Reduced 74.41%	18,301 $6,000
Q3 2022 Nov 14, 2022	SELL	$0.45 - $0.69 $6,548 - $10,040	-14,552 Reduced 16.91%	71,503 $36,000
Q2 2022 Aug 12, 2022	SELL	$0.42 - $0.78 $4,071 - $7,561	-9,694 Reduced 10.12%	86,055 $49,000
Q1 2022 May 16, 2022	BUY	$0.7 - $1.51 $37,989 - $81,947	54,270 Added 130.84%	95,749 $68,000
Q4 2021 Feb 08, 2022	SELL	$1.16 - $2.23 $3,781 - $7,269	-3,260 Reduced 7.29%	41,479 $54,000
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $79,425 - $152,114	35,458 Added 382.05%	44,739 $103,000
Q2 2021 Sep 13, 2021	BUY	$4.39 - $7.23 $40,743 - $67,101	9,281 New	9,281 $41,000

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.